Scarica l'app Stockscreener
76.59
2.98%
-2.35
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$78.94
Aprire:
$78.68
Volume 24 ore:
324.58K
Relative Volume:
0.58
Capitalizzazione di mercato:
$2.93B
Reddito:
-
Utile/perdita netta:
$-241.60M
Rapporto P/E:
-11.58
EPS:
-6.6167
Flusso di cassa netto:
$-201.34M
1 W Prestazione:
+0.43%
1M Prestazione:
+13.89%
6M Prestazione:
-1.98%
1 anno Prestazione:
+32.05%
Intervallo 1D:
$74.99
$79.80
Intervallo di 1 settimana:
$73.93
$82.50
Portata 52W:
$40.00
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
Nome
Disc Medicine Inc
Settore
Industria
Telefono
(617) 674-9274
Indirizzo
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
76.59 | 2.93B | 0 | -241.60M | -201.34M | -6.6167 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-03 | Ripresa | Stifel | Buy |
| 2025-07-21 | Iniziato | Truist | Buy |
| 2025-07-03 | Ripresa | Morgan Stanley | Overweight |
| 2025-06-11 | Ripresa | Raymond James | Strong Buy |
| 2025-02-27 | Iniziato | TD Cowen | Buy |
| 2024-11-05 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-22 | Iniziato | Wells Fargo | Overweight |
| 2024-04-01 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-05-17 | Iniziato | Raymond James | Outperform |
| 2023-04-28 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Iniziato | Stifel | Buy |
| 2023-04-20 | Iniziato | Morgan Stanley | Overweight |
| 2023-03-23 | Iniziato | BMO Capital Markets | Outperform |
| 2023-02-28 | Iniziato | SVB Securities | Outperform |
Mostra tutto
Disc Medicine Inc Borsa (IRON) Ultime notizie
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Price to earnings forward of Disc Medicine, Inc. – BOATS:IRON - TradingView
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - PR Newswire
Disc Medicine COO Jonathan Yu sells $8,250 in stock By Investing.com - Investing.com Nigeria
Form 4 Disc Medicine Inc For: 9 July By Investing.com - Investing.com Canada
Disc Medicine COO Jonathan Yu sells $8,250 in stock - Investing.com
Disc Medicine (IRON) COO trades 100 shares after option exercise under 10b5-1 plan - Stock Titan
Why Disc Medicine's Extended Hercules Credit Access Could Reshape IRON's Funding Flexibility Narrative - simplywall.st
Disc Medicine Investor News: If You Have Suffered Losses in - GlobeNewswire
(IRON) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Broker files Form 144 for 10,000 IRON shares (IRON) — option exercise sale - Stock Titan
IRON Q1 2026 Earnings: Narrower-than-expected loss highlights cost control amid clinical progressLong-Term Guidance - dars.gov.et
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), ... - Caledonian Record
Disc Medicine (IRON) Could Be 67% Undervalued On Its $30 Million Loan Reset - Sahm
Did Disc Medicine’s Expanded Hercules Credit Access Just Shift IRON’s Funding Risk Profile? - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Encourages Disc Medicine, Inc - The National Law Review
Disc Medicine’s chief legal officer sells $187,500 in stock - Investing.com UK
Disc Medicine COO Jonathan Yu sells $21,750 in company stock By Investing.com - Investing.com South Africa
Form 4 Disc Medicine Inc For: 30 June By Investing.com - Investing.com Nigeria
Disc Medicine’s chief legal officer sells $187,500 in stock By Investing.com - Investing.com Nigeria
Disc Medicine COO Jonathan Yu sells $21,750 in company stock - Investing.com
Disc Medicine (NASDAQ: IRON) CLO exercises options, sells 2,500 common shares - Stock Titan
Disc Medicine (NASDAQ: IRON) COO exercises options and sells 300 shares - Stock Titan
Disc Medicine Amends Loan Agreement, Expands Debt Capacity - TipRanks
Disc MedicineEnters First Amendment To Loan Agreement On June 25, 2026SEC Filing - TradingView
Disc Medicine (NASDAQ: IRON) extends Hercules loan access and covenants - Stock Titan
Morgan Stanley Maintains Disc Medicine(IRON.US) With Buy Rating, Raises Target Price to $85 - Moomoo
Enterprise value to revenue forward of Disc Medicine, Inc. – NASDAQ:IRON - TradingView
Price to book forward of Disc Medicine, Inc. – NASDAQ:IRON - TradingView
Price to sales forward of Disc Medicine, Inc. – NASDAQ:IRON - TradingView
Enterprise value to EBITDA forward of Disc Medicine, Inc. – NASDAQ:IRON - TradingView
(IRON) Risk Channels and Responsive Allocation - Stock Traders Daily
Form 144 Disc Medicine For: 26 June By Investing.com - Investing.com Nigeria
IRON Stock Climbs As Clinical Wins Offset Insider Selling - timothysykes.com
IRON (NASDAQ: IRON) notice: proposed 2,500-share option sale; prior 7,500-share 10b5-1 - Stock Titan
Disc Medicine, Inc. Actuals & Estimates (NASDAQ:IRON) - TradingView
12 Health Care Stocks Moving In Friday's After-Market Session - Sahm
Form 4 Disc Medicine Inc For: 24 June By Investing.com - Investing.com Australia
Disc Medicine COO Jonathan Yu sells $704,795 of iron common stock - Investing.com UK
Disc Medicine, Inc. (IRON) 8-K Filing: Company Details, Nasdaq Listing, and Contact Info – June 2026 - Minichart
Disc Medicine Inc Azioni (IRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Disc Medicine Inc Azioni (IRON) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Yu Jonathan Yen-Wen | Chief Operating Officer |
Jul 07 '26 |
Sale |
82.50 |
100 |
8,250 |
54,324 |
2.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):